Personal information

No personal information available

Activities

Collapse all

Works (15)

Variance in the composition and number of VLDL and LDL particles with increasing triglyceride or increasing ApoB concentrations

Journal of Clinical Lipidology
2025-01 | Journal article
DOI: 10.1016/j.jacl.2024.09.009
Contributors: Justine Cole; Patrick Couture; André J. Tremblay; Allan D. Sniderman
Source: check_circle
Crossref

Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational Study

Arteriosclerosis, Thrombosis, and Vascular Biology
2024-10 | Journal article
DOI: 10.1161/ATVBAHA.124.321165
Contributors: Selin Bilgic; Karol M. Pencina; Michael J. Pencina; Justine Cole; Line Dufresne; George Thanassoulis; Allan D. Sniderman
Source: check_circle
Crossref

Discordance among apoB, non–high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention

European Heart Journal
2024-07-12 | Journal article
DOI: 10.1093/eurheartj/ehae258
Contributors: Allan D Sniderman; Line Dufresne; Karol M Pencina; Selin Bilgic; George Thanassoulis; Michael J Pencina
Source: check_circle
Crossref

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol

Journal of the American Heart Association
2023-08 | Journal article
DOI: 10.1161/JAHA.123.030405
Contributors: John H. Contois; Michel R. Langlois; Christa Cobbaert; Allan D. Sniderman
Source: check_circle
Crossref

Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?

Journal of Clinical Lipidology
2023-07 | Journal article
DOI: 10.1016/j.jacl.2023.05.093
Contributors: Davide De Marco; Karol Pencina; Michael Pencina; Line Dufresne; George Thanassoulis; Allan D. Sniderman
Source: check_circle
Crossref

Cholesterol, Coronary Calcification, and Cardiovascular Prevention: Lessons We Can Learn From the Western Denmark Heart Registry

Circulation
2023-04-04 | Journal article
DOI: 10.1161/CIRCULATIONAHA.123.063658
Contributors: Elie Akl; Allan D. Sniderman
Source: check_circle
Crossref

dal-GenE was negative—not positive except for COVID-19

European Heart Journal
2022-12-21 | Journal article
DOI: 10.1093/eurheartj/ehac637
Contributors: Allan D Sniderman
Source: check_circle
Crossref

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

Journal of the American Heart Association
2022-10-18 | Journal article
DOI: 10.1161/JAHA.122.025858
Contributors: Tamara Glavinovic; George Thanassoulis; Jacqueline de Graaf; Patrick Couture; Robert A. Hegele; Allan D. Sniderman
Source: check_circle
Crossref

Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study

Journal of the American Heart Association
2021-09-07 | Journal article
DOI: 10.1161/JAHA.120.019890
Contributors: John T. Wilkins; Henrique S. Seckler; Jonathan Rink; Philip D. Compton; Luca Fornelli; C. Shad Thaxton; Rich LeDuc; David Jacobs; Peter F. Doubleday; Allan Sniderman et al.
Source: check_circle
Crossref

Clinical reasoning and prevention of cardiovascular disease

Journal of Clinical Lipidology
2021-05 | Journal article
DOI: 10.1016/j.jacl.2021.04.001
Contributors: Sniderman Allan; Michael Pencina; George Thanassoulis
Source: check_circle
Crossref

Effects of apolipoprotein B on the lifespan and risks of major disease including type 2 diabetes: a Mendelian randomization analysis using outcomes in first-degree relatives

2020-11-12 | Other
DOI: 10.1101/2020.11.09.20227801
Contributors: Tom G Richardson; Qin Wang; Eleanor Sanderson; Anubha Mahajan; Mark I McCarthy; Timothy M. Frayling; Mika Ala-Korpela; Allan Sniderman; George Davey Smith; Michael V Holmes
Source: check_circle
Crossref

Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study

Journal of the American Heart Association
2020-09-15 | Journal article
DOI: 10.1161/JAHA.119.014711
Contributors: Mehdi Afshar; Jian Rong; Yang Zhan; Hao Yu Chen; James C. Engert; Allan D. Sniderman; Martin G. Larson; Ramachandran S. Vasan; George Thanassoulis
Source: check_circle
Crossref

Prevention of cardiovascular disease: time for a course correction

European Heart Journal
2020-08-14 | Journal article
DOI: 10.1093/eurheartj/ehaa259
Contributors: Allan D Sniderman; George Thanassoulis; Michael Pencina
Source: check_circle
Crossref

The Expected 30-year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering

Circulation
2020-07-23 | Journal article
DOI: 10.1161/CIRCULATIONAHA.120.045851
Contributors: Michael Pencina; Karol Pencina; Donald Lloyd-Jones; Alberico L. Catapano; George Thanassoulis; Allan D. Sniderman
Source: check_circle
Crossref

The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease

Journal of Clinical Lipidology
2014-11 | Journal article
DOI: 10.1016/j.jacl.2014.08.004
Contributors: Peter P. Toth; George Thanassoulis; Ken Williams; Curt D. Furberg; Allan Sniderman
Source: check_circle
Crossref

Peer review (7 reviews for 1 publication/grant)

Review activity for Journal of clinical lipidology. (7)
How many people are using ORCID?